It tookalmost aquarterof acenturyfrom the earliest indication that steroid hormones play a role in transcriptional control, triggered by the observation by Ulrich Clever of ecdysoneinduced giant chromosome puffs, and from the earliest detection of steroid hormone receptors (SHRs) to the cloning of their genes (reviewed by Evans, 1988) . Although availability of the first SHR cDNA clones 10 years ago triggered the isolation of the now huge superfamily of nuclear receptors by homology screening with the DNAbinding domain (DBD) (Mangelsdorf and Evans, 1995 [this issue of Cell] ; Thummel, 1995 [this issue of CeW]), the vertebrate SHRs have remained a distinct class that are different in several respects from all other nuclear receptors.
Prologue: The Main Actors SHRs exert their influence in embryonic development and adult homeostasis as hormone-activated transcriptional regulators. Their modular structure, consisting of a DBD, nuclear localization signals, a ligand-binding domain (LBD), and several transcriptional activation functions (AFs) (Figure l) , is conserved with other members of the nuclear receptor family. Unique to the SHRs is their ability upon activation to bind to palindromic DNA sequences, called hormone response elements (HREs) (Figure l) , exclusively as homodimers, at least in vivo. The receptors for glucocorticoids, mineralocorticoids, progesterone, and androgens recognize the same DNA sequence (AGAACA as half-site) that creates a specificity problem to be discussed later, while the estrogen receptor recognizes AGG-TCA, identical with the half-site used by the nonsteroid nuclear receptors. Mutant data, nuclear magnetic resonance studies, and X-ray analyses of DBDlHRE cocrystals of glucocorticoid and estrogen receptors have shown that half-sites are distinguished by several amino acids (originally named the P box by Umesono and Evans, 1989 ) of a recognition helix that is coordinated by a zinc-binding motif and makes base-specific contacts within the major groove. A second zinc atom organizes both an a helix, which is oriented alongside the axis of the DNA, and the D box, responsible, at least in part, for specific homodimerization ( Figure 1 ; reviewed by Glass, 1994) . After binding to DNA, the receptor is thought to interact with components of the basal transcriptional machinery and with sequence-specific transcription factors. Although a number of such interactions have been described, the actual mechanism of steroid hormone action is still far from being understood. We know many actors, but we do not know the plot. The only certainty is that there are many more actors than expected and that the plot they are involved in is neither simple nor unique. In reviewing the wealth of recent reports on SHRs, we will describe various levels of regulation, focusing on a few well-characterized examples of hormonal induction and repression and on the insights gained by targeted disruption of the genes for SHRs.
The Curtain Rises: The Unliganded SHR Complex In contrast with other nuclear receptors, all unliganded SHRs are associated with a large multiprotein complex of chaperones, including Hsp90 and the immunophilin Hsp56, which maintains the receptors in an inactive but ligand-friendly conformation (reviewed by Pratt, 1993). SHRs introduced into yeast can be activated upon ligand addition. Data obtained in mutant yeast strains suggest that the chaperoning proteins play an active role in keeping SHRs functional. In yeast strains expressing the glucocorticoid receptor, disruption of the Hsp90 homologs does not lead to constitutive activation of the receptor but rather to a significant impairment of hormone induction (Bohen and Yamamoto, 1993) . Chaperones in addition to Hsp90 are required for SHR function, as suggested by mutants of the yeast dnaJ homolog YDJl , which also associates with the unliganded SHR complex. In contrast with mutants found in hsp90, one ydil allele generates constitutively active estrogen and glucocorticoid receptors (CapIan et al., 1995; Kimura et al., 1995) .
Other Members of the Cast: Basal Transcription Factors and Coactivators To regulate transcription, liganded SHRs must talk to the transcription initiation complex. It is currently debated whether transcription initiation complexes assemble at the TATA box in an ordered stepwise fashion (TFIID > TFIIB > RNA polymerase II + TFIIF > TFIIE > TFIIH) or are recruited as preformed complexes. Such preformed holoenzyme complexes, containing RNA polymerase II and all relevant general transcription factors along with several additional polypeptides, exist in yeast (Kim et al., 1994; Koleske and Young, 1994) and in higher eukaryotes (Ossipow et al., 1995) .
SHRs have been shown to interact in vitro directly with components of the transcription initiation complex (reviewed by Tsai and O'Malley, 1994) , but the physiological significance of these interactions remains unclear. There have also been indications for the existence of coactivators that would act as bridging factors between SHRs and the transcription initiation complex. A number of such intermediary factors that interact with AF2 at the C-terminus Saatcioglu et al., 1994) . Many of these conclusions rely on cotransfection experiments and therefore need to be taken with caution. How can bona fide transcription factors be converted into repressors? An interesting hint has come from the observation that glucocorticoid receptor and Jun homodimers synergize, while glucocorticoid receptor represses Fos-Jun heterodimers (Yamamoto et al., 1993; Teurich and Angel, 1995) , which suggests conformational changes by protein-protein interaction as basis for altered activity. An influence of DNA on SHR conformation has been postulated (reviewed by Yamamoto et al., 1993; Lefstin et al., 1994) . While well known for RXR heterodimers (Mangelsdorf et al., 1991; Saatcioglu et al., 1994) , data for glucocorticoid receptor modulation by so-called negative HREsand composite elements are not persuasive. Binding of glucocorticoid receptor to such elements has yet only been shown in vitro (but not in vivo, e.g., by genomic footprinting) and often requires high concentration of recombinant receptor.
It therefore appears that, as a common principle, SHRs can exist in a transactivating or a repressing conformation in which the activation domains are disguised (Figure 2) . Interacting proteins and ligands convert one form into the other. Protein-protein interaction can be mutual, and not only the synergy but also the inhibition occur with only one factor bound to DNA. It is not yet clear whether these rules of mutual interactions as described for SHRs and AP-1 can be applied to other transcription factors such as GATAl and Spil and to putative cell type-specific factors modulating SHR transcription factor cross-talk, all of which we have not covered here.
The interference of SHRs with the other important factor of the inflammatory response, NF-KB, has only recently been studied. Overexpression of ~65, one of the transcriptionally active subunits of NF-KB, and of glucocorlicoid receptor, as well as in vitro binding between p65 and receptors for either glucocorticoid, progesterone, or estrogen suggest a mutual interference mechanism as for AP-1 (Stein et al., 1993; Ray and Prefontaine, 1994; Stein and Yang, 1995; Caldenhoven et al., 1995; Scheinman et al., 1995a) . In keeping with this notion, interleukin-2 expression by a leukemic cell line selected for glucocorticoidinducible apoptosis is inhibited by a transactivationdefective glucocorticoid receptor mutant (Helmberg et al., 1995) . The glucocorticoid receptor seems to block NF-KB DNA binding as measured by bandshifts in vitro. Inhibition by glucocorticoid of promoters containing NF-KB sites could, on the other hand, be explained by the recent finding of rapid induction of lKBa synthesis in response to hormone (Scheinman et al., 1995b; Auphan et al., 1995) . IKB traps NF-KB in the cytoplasm, and its increased synthesis may revert NF-KB binding to promoters. These interesting findings reopen the debate on the antiinflammatory action and induction of apoptosis by SHRs. Is the balance between apoptosis and survival regulators disturbed by the interference with a survival pathway or by induction of a suicide gene? Although indications exist (Auphan et In the well-known assembly with individual DNA elements in the same promoter (A), transcription factors in their transactivating (circle) conformation interact with coactivators and, in an unknown fashion, bundle their stimuli to the transcriptional initiation complex. Two different transcription factors can also act from one promoter element, envisaged here as synergy (6) of, e.g., a Jun homodimer at an AP-I-binding site with the glucocorticoid receptor and as repression (C). The latter interaction needs to alter the conformation of the partners (shown as rectangles, concealing the activation domains). The glucocorticoid receptor may repress as a monomer (see text) and engage corepression. Direct protein-protein interaction of the transcription factors, perhaps with participation of tissue-specific additional factors, determines the regulatory properties.
al. , 1995; Berko-Flint et al., 1994) , the relevance of negative regulation by SHRs in the intact organism awaits convincing demonstration, e.g., by appropriate rodent or human mutants.
Do the Actors Need a Revolving Stage?: Role for Chromatin
The interaction between proteins and DNA and among SHRs, transcription factors, and the initiation complex has to cope with the structural organization of DNA in the nucleus. Genetic analysis has revealed a widespread involvement of chromatin structure in gene regulation. Transactivation by glucocorticoid receptor in yeast requires components of the SWllSNF complex (Yoshinaga et al., 1992) , a set of pleiotropic transactivators that counteract repressing functions of chromatin and are therefore important for transcription of inducible genes (Winston and Carlson, 1992) . In human cells lacking a homolog of SWl2, human Brm (hBrm), transactivation by glucocorticoid receptor is weak and can be selectively enhanced by expression of hBrm (Muchardt and Yaniv, 1993) . Like SW12 in yeast, hBrm is part of a large multiprotein complex that mediates ATP-dependent disruption of a nucleosome and enables binding of GAL-linked transactivators to GALC binding sites in nucleosomes (Kwon et al., 1994) . Asecond human homolog, BRGl, is a nuclear protein that can restore glucocorticoid receptor-dependent transcription in yeast strains lacking SW12 (Khavari et al., 1993) . BRGl binds specifically the retinoblastoma gene product Rb, and Rb up-regulates glucocorticoid receptor-mediated transactivation only in the presence of hBrm (Singh et al., 1995) . These results document the link between SHR and the complex cellular machinery involved in chromatin dynamics and cell cycle control.
One of the Scenes: The Mouse Mammary Tumor Virus Promoter The mouse mammary tumor virus (MMTV) promoter is a well-documented example of transcriptional control by steroid hormones. The SHRs bind to several HREs and facilitate the interaction of other transcription factors, including nuclear factor 1 (NFl) and the octamer transcription factor OTFl , with the MMTV promoter (reviewed by Truss and Beato, 1993) . Nucleosomes are nonrandomly distributed on the MMTV promoter (Richard-Foy and Hager, 1987) , though a more heterogeneous distribution of nucleosome positions is found by formaldehyde fixation (Fragoso et al., 1995) . One dominant nucleosome phase found both in mammalian cells and in yeast carrying an MMTV promoter permits SHR binding to HREs while precluding binding of NFI (Truss et al., 1995; Chavez et al., 1995) . This difference probably reflects the different ways in which various proteins recognize their cognate DNA sites (Figure 3 ). Such data imply that DNA contains conformational or topological information that is implemented in chromatin and modulates the accessibility to &-acting elements.
Hormone induction was believed to cause a displacement of the nucleosome over the HREs, thus allowing free access of NFl to its binding site and transcriptional activation (Richard-Foyand Hager, 1987) . However, genomic footprinting of the chromosomal MMTV promoter shows that hormone induction does not lead to displacement, but rather to a rearrangement of the nucleosome that enables simultaneous binding of receptors, NFl and OTFl (Truss et al., 1995) . Since these factors cannot bind simultaneously to the MMTV promoter on free DNA, the organization in chromatin may beaprerequisiteforoptimal induction of the MMTV promoter. One attractive possibility is that the hormone-induced nucleosomal change may be related to the recently observed receptor-mediated recruitment of the SWllSNF complex or of other chromatin remodeling factors (Figure 4) .
Knockout of the Players Provides New Insights into Old Problems
Even though a wealth of information on steroid action is available, the generation of mice with mutations in the major vertebrate SHRs by homologous recombination in embryonic stem cells has generated new and often unexpected insights. With the exception of the androgen insensitivity syndrome (reviewed by McPhaul et al., 1993) and (8) Proteins, like SHRs, which contact only a narrow sector of the helix (around 100°), would bind if the major groove were exposed (orientation l), but not if it pointed to the histone octamer (orientation 2) (Li and Wrange, 1995) .
the recent description of a male with a mutation in the estrogen receptor gene (Smith et al., 1994) , no complete loss-of-function mutation in other human or murine SHR genes has been described that suggested that complete loss of any one of these receptors might lead to embryonic lethality. This suspicion has been substantiated for null mutations in mice of the glucocorticoid receptor, but not for the sex steroid receptors. Glucocorticoid Receptor Disruption of the glucocorticoid receptor gene is expected to interfere with many physiological processes, such as regulation of carbohydrate, protein and lipid metabolism, and modulation of immune and central nervous system (CNS) responses. Unexpectedly, the analysis of the glucocorticoid receptor-negative mice revealed that the receptor is also required for maturation of several organ systems, e.g., lung and adrenal gland (Cole et al., 1995) , perhaps also explaining why so far only partial loss-offunction mutations have been observed in humans. Most of the glucocorticoid receptor-deficient mice die shortly after birth owing to respiratory failure caused by lack of inflation of the lungs, likely resulting from lowered production of surfactants and from deficiency of a glucocorticoidinducible sodium channel. The adrenals of mutant mice lack adrenergic chromaffine cells from day 13 of embryonic development. These cells are derived from a bipotential neural crest cell population that, depending on environ- 
